361 related articles for article (PubMed ID: 31978522)
1. Novel approaches for the delivery of therapeutics in ischemic stroke.
Nozohouri S; Sifat AE; Vaidya B; Abbruscato TJ
Drug Discov Today; 2020 Mar; 25(3):535-551. PubMed ID: 31978522
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent and long-term cerebroprotective effects of intranasal delivery of progesterone after ischemic stroke in male mice.
Fréchou M; Zhu X; Liere P; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2020 Jun; 170():108038. PubMed ID: 32151648
[TBL] [Abstract][Full Text] [Related]
3. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
Fukuta T
Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicinal Strategies as Emerging Therapeutic Avenues to Treat and Manage Cerebral Ischemia.
Fatima S; Quadri SN; Parveen S; Beg S; Barkat MA; Samim M; Abdin MZ; Ahmad FJ
CNS Neurol Disord Drug Targets; 2021; 20(2):125-144. PubMed ID: 33138766
[TBL] [Abstract][Full Text] [Related]
5. Probing the drug delivery strategies in ischemic stroke therapy.
Wu Q; Yan R; Sun J
Drug Deliv; 2020 Nov; 27(1):1644-1655. PubMed ID: 33241704
[TBL] [Abstract][Full Text] [Related]
6. Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury.
Xu F; Hongbin Han ; Yan J; Chen H; He Q; Xu W; Zhu N; Zhang H; Zhou F; Lee K
Drug Deliv; 2011; 18(7):461-7. PubMed ID: 21923252
[TBL] [Abstract][Full Text] [Related]
7. The effects of erythropoietin on neurogenesis after ischemic stroke.
Zhang SJ; Luo YM; Wang RL
J Integr Neurosci; 2020 Sep; 19(3):561-570. PubMed ID: 33070534
[TBL] [Abstract][Full Text] [Related]
8. Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke.
Jin W; Wu Y; Chen N; Wang Q; Wang Y; Li Y; Li S; Han X; Yang E; Tong F; Wu J; Yuan X; Kang C
Theranostics; 2021; 11(17):8197-8217. PubMed ID: 34373737
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery systems for the treatment of ischemic stroke.
Rhim T; Lee DY; Lee M
Pharm Res; 2013 Oct; 30(10):2429-44. PubMed ID: 23307348
[TBL] [Abstract][Full Text] [Related]
10. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
[TBL] [Abstract][Full Text] [Related]
11. Salidroside as a potential neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety.
Fan F; Yang L; Li R; Zou X; Li N; Meng X; Zhang Y; Wang X
Biomed Pharmacother; 2020 Sep; 129():110458. PubMed ID: 32603893
[TBL] [Abstract][Full Text] [Related]
12. Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.
Nilles KL; Williams EI; Betterton RD; Davis TP; Ronaldson PT
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163820
[TBL] [Abstract][Full Text] [Related]
13. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
Fukuta T; Ishii T; Asai T; Oku N
Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
[TBL] [Abstract][Full Text] [Related]
14. A series of novel neuroprotective blood brain barrier penetrating flavonoid drugs to treat acute ischemic stroke.
Lapchak PA
Curr Pharm Des; 2012; 18(25):3694-703. PubMed ID: 22574983
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of Tong-Qiao-Huo-Xue Decoction on Inflammatory Injury Caused by Intestinal Microbial Disorders in Stroke Rats.
Zhang F; Zhai M; Wu Q; Jia X; Wang Y; Wang N
Biol Pharm Bull; 2020 May; 43(5):788-800. PubMed ID: 32132347
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective delivery platforms as an adjunct to mechanical thrombectomy.
Babadjouni RM; Walcott BP; Liu Q; Tenser MS; Amar AP; Mack WJ
Neurosurg Focus; 2017 Apr; 42(4):E4. PubMed ID: 28366053
[TBL] [Abstract][Full Text] [Related]
18. Altered plasma and brain disposition of isopropylidene shikimic acid liposome in rats and the brain protection in cerebral ischemia-reperfusion.
Qu C; Ni J; Yang P; Zhang H; Lin L; Li J; Tian J; Fu J; Yin X; Kong H
Drug Dev Ind Pharm; 2013 Sep; 39(9):1291-5. PubMed ID: 23020069
[TBL] [Abstract][Full Text] [Related]
19. The effect of cyclosporin a on ischemia-reperfusion damage in a mouse model of ischemic stroke.
Deng H; Zhang S; Ge H; Liu L; Liu L; Feng H; Chen L
Neurol Res; 2020 Sep; 42(9):721-729. PubMed ID: 32529968
[TBL] [Abstract][Full Text] [Related]
20. Advances in nanomedicines: a promising therapeutic strategy for ischemic cerebral stroke treatment.
Li J; Xie F; Ma X
Nanomedicine (Lond); 2024 Apr; 19(9):811-835. PubMed ID: 38445614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
